Posted on December 10, 2008 11:55
Categories: Medicaid | Mental Health | State and Local
Topics: Medicaid | Mental Health | Prescription Drugs | Spending | State Data
Using data from Georgia and Mississippi, this study assesses the effects of step-therapy prior authorization policy for atypical anti-psychotic medications on overall Medicaid expenditures as well as specific expenditures among schizophrenia patients.
Farley, J. F., Cline, R. R., Schommer, J. C., Hadsall, R. S., & Nyman, J. A. (2008). Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clinical Therapeutics, 30(8): 1524-39; discussion 1506-7. DOI:10.1016/j.clinthera.2008.08.009
Authors: Joel F. Farley, Richard R. Cline, Jon C. Schommer, Ronald S. Hadsall, John A. Nyman
E-mail to Friend |
Print |
Permalink |
Post RSS
